Long-acting injectable cabotegravir (CAB-LA) was safe and well tolerated as HIV pre-exposure prophylaxis (PrEP) before and during pregnancy in the follow-up phase of a global study among cisgender women.
Long-acting injectable CAB-LA safe for HIV PrEP during pregnancy, study finds
- Post author:
- Post published:July 23, 2024
- Post category:uncategorized